Biguanides and NIDDM
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The main biguanides, metformin and phenformin, were introduced in 1957 as oral glucose-lowering agents to treat non-insulin-dependent diabetes mellitus (NIDDM). Phenformin was withdrawn in many countries because of an association with lactic acidosis, but metformin does not have the same risk if appropriately prescribed. Metformin is now widely used as a monotherapy and in combination with a sulfonylurea. Unlike sulfonylureas, metformin is not bound to plasma proteins, is not metabolized, and is eliminated rapidly by the kidney. The glucose-lowering effect occurs without stimulation of insulin secretion and results mainly from increased glucose utilization. The presence of insulin is required, and enhancement of insulin action at the postreceptor level occurs in peripheral tissues such as muscle. In peripheral tissues metformin increases insulin-mediated glucose uptake and oxidative metabolism. Metformin also increases glucose utilization by the intestine, primarily via nonoxidative metabolism. The extra lactate produced is largely extracted by the liver and serves as a substrate to sustain gluconeogenesis. This limits the extent to which metformin reduces hepatic glucose production but provides a safeguard against excessive glucose lowering. Because metformin does not cause clinical hypoglycemia, it is actually an antihyperglycemic drug. It does not cause weight gain, it helps combat hypertriglyceridemia, and it has been ascribed some vasoprotective properties. Metformin offers a useful treatment for insulin-resistant overweight NIDDM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Diabetes and atherosclerosis: An epidemiologic view
Pyörälä, K., Laakso, M., & Uusitupa, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 919
Oates, J. A., Wood, A. J. J., & Gerich, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911023211805 · Cited by 480
Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM
Consoli, A., Nurjhan, N., Capani, F., & Gerich, J. (1989) · Diabetes · doi:10.2337/diab.38.5.550 · Cited by 406
Reduction of metformin renal tubular secretion by cimetidine in man.
Somogyi, A., Stockley, C., Keal, J., Rolan, P., & Bochner, F. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03090.x · Cited by 282
Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients
Wu, M.-S., Johnston, P., Sheu, W.-H., Hollenbeck, C., Jeng, C.-Y., Goldfine, I., Chen, Y.-D., & Reaven, G. (1990) · Diabetes Care · doi:10.2337/diacare.13.1.1 · Cited by 257
Mechanism of metformin action in non-insulin-dependent diabetes
Jackson, R. A., Hawa, M. I., Jaspan, J. B., Sim, B. M., DiSilvio, L., Featherbe, D., & Kurtz, A. B. (1987) · Diabetes · doi:10.2337/diab.36.5.632 · Cited by 202
Vague, P., Juhan-Vague, I., Alessi, M. C., Badier, C., & Valadier, J. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651126 · Cited by 165
Atherosclerosis in diabetes: The role of hyperinsulinemia
STOLAR, M. W. (1988) · Metabolism · doi:10.1016/0026-0495(88)90180-1 · Cited by 161
Effect of metformin on glucose metabolism in the splanchnic bed
Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 129
Self-citationMetformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
Hother-Nielsen, O., Schmitz, O., Andersen, P. H., Beck-Nielsen, H., & Pedersen, O. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1200257 · Cited by 117
Effect of metformin on glucose metabolism in mouse soleus muscle.
Bailey, C. J., & Puah, J. A. (1986) · PubMed · Cited by 112
Self-citationInhibition of hepatic gluconeogenesis by metformin
Wollen, N., & Bailey, C. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90617-x · Cited by 111
Self-citationDiarrhea and Metformin in a Diabetic Clinic
Dandona, P., Fonseca, V., Mier, A., & Beckett, A. G. (1983) · Diabetes Care · doi:10.2337/diacare.6.5.472 · Cited by 109
Specific Inhibition of Gluconeogenesis by Biguanides
Meyer, F., Ipaktchi, M., & Clauser, H. (1967) · Nature · doi:10.1038/213203a0 · Cited by 109
Nosadini, R., Avogaro, A., Trevisan, R., Valerio, A., Tessari, P., Duner, E., Tiengo, A., Velussi, M., Del Prato, S., De Kreutzenberg, S., et al. (1987) · Diabetes Care · doi:10.2337/diacare.10.1.62 · Cited by 109
Clarke, B. F., & Duncan, L. J. P. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92726-8 · Cited by 108
Groop, L., Wid�n, E., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Schalin, C., & Eriksson, J. G. (1989) · Diabetologia · doi:10.1007/bf00285334 · Cited by 105
Pénicaud, L., Hitier, Y., Ferré, P., & Girard, J. (1989) · Biochemical Journal · doi:10.1042/bj2620881 · Cited by 105
Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes
Pagano, G., Tagliaferro, V., Carta, Q., Caselle, M. T., Bozzo, C., Vitelli, F., Trovati, M., & Cocuzza, E. (1983) · Diabetologia · doi:10.1007/bf00251823 · Cited by 94
The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?
Peacock, I., & Tattersall, R. B. (1984) · BMJ · doi:10.1136/bmj.288.6435.1956 · Cited by 94
Metformin Revisited: Its Actions and Indications for Use
Bailey, C. J. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00996.x · Cited by 90
Self-citationClarke, B. F., & Campbell, I. W. (1977) · BMJ · doi:10.1136/bmj.2.6102.1576 · Cited by 89
Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*
Fantus, I. G., & Brosseau, R. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-898 · Cited by 88
Subcellular Distribution of Metformin in Rat Liver
Wilcock, C., Wyre, N. D., & Bailey, C. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03507.x · Cited by 86
Self-citationMetformin and the sulphonylureas: the comparative risk.
Campbell, I. W. (1985) · PubMed · Cited by 85
Bailey, C. J., & Nattrass, M. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80043-0 · Cited by 84
Self-citationCallaghan, T. S., Hadden, D. R., & Tomkin, G. H. (1980) · BMJ · doi:10.1136/bmj.280.6225.1214 · Cited by 77
The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes
Rains, S. G. H., Wilson, G. A., Richmond, W., & Elkeles, R. S. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01074.x · Cited by 75
Sulphonylurea Failure in Type 2 Diabetes: Treatment with a Basal Insulin Supplement
Holman, R. R., Steemson, J., & Turner, R. C. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00909.x · Cited by 73
Nattrass, M., Todd, P. G., Hinks, L. J., Lloyd, B. B., & Alberti, K. G. M. M. (1977) · Diabetologia · doi:10.1007/bf00745143 · Cited by 72
Comparison of Tolbutamide and Metformin in Elderly Diabetic Patients
Josephkutty, S., & Potter, J. M. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01433.x · Cited by 70
Beck‐Nielsen, H., Nielsen, O. H., & Pedersen, O. B. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01068.x · Cited by 70
Sites of metformin-stimulated glucose metabolism
Wilcock, C., & Bailey, C. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90136-9 · Cited by 67
Self-citationTomkin, G. H. (1973) · BMJ · doi:10.1136/bmj.3.5882.673 · Cited by 67
Metformin Improves Peripheral Vascular Flow in Nonhyperlipidemic Patients with Arterial Disease
Sirtori, C. R., Franceschini, G., Gianfranceschi, G., Sirtori, M., Montanari, G., Bosisio, E., Mantero, E., & Bondioli, A. (1984) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198409000-00027 · Cited by 66
Collier, A., WATSON, H. H. K., Patrick, A. W., Ludlam, C. A., & Clarke, B. F. (1989) · PubMed · Cited by 64
Biguanides and Sulfonylureas as Combination Therapy in NIDDM
Hermann, L. S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.37 · Cited by 61
Reconsideration of inhibitory effect of metformin on intestinal glucose absorption
Wilcock, C., & Bailey, C. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb06645.x · Cited by 60
Self-citationBiguanide Treatment Increases the Number of Insulin-Receptor Sites on Human Erythrocytes
Holle, A., Mangels, W., Dreyer, M., Kühnau, J., & Rüdiger, H. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051007 · Cited by 59
The status of metformin in Canada.
Lucis, O. J. (1983) · PubMed · Cited by 59
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE
Chakrabarti, R., Hocking, E., & Fearnley, G. R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92383-4 · Cited by 52
The Influence of Guar Gum on Absorption of Metformin from the Gut in Healthy Volunteers
Gin, H., Orgerie, M., & Aubertin, J. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009156 · Cited by 51
Rains, S. G. H., Wilson, G. A., Richmond, W., & Elkeles, R. S. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200213 · Cited by 48
Campbell, I. W., Duncan, C. A., Patton, N. W., Broadhead, T., Tucker, G. T., & Woods, H. F. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00895.x · Cited by 44
Pedersen, O., Nielsen, O. H., Bak, J., Richelsen, B., Beck‐Nielsen, H., & Sørensen, N. S. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01156.x · Cited by 41
Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes
Jacobs, D. B., Hayes, G. R., Truglia, J. A., & Lockwood, D. H. (1986) · Diabetologia · doi:10.1007/bf00873219 · Cited by 40
Rigas, A. N., Bittles, A. H., Hadden, D. R., & Montgomery, D. A. D. (1968) · BMJ · doi:10.1136/bmj.4.5622.25 · Cited by 39
Melin, B., Cherqui, G., Eggelpoël, M.-J. B.-V., Caron, M., Lascols, O., Capeau, J., & Picard, J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90171-8 · Cited by 38
Lord, J. M., Atkins, T. W., & Bailey, C. J. (1983) · Diabetologia · doi:10.1007/bf00250897 · Cited by 37
Self-citationImprovement With Metformin in Insulin Internalizaron and Processing in Monocytes From NIDDM Patients
Benzi, L., Trischitta, V., Ciccarone, A., Cecchetti, P., Brunetti, A., Squatrito, S., Marchetti, P., Vigneri, R., & Navalesi, R. (1990) · Diabetes · doi:10.2337/diab.39.7.844 · Cited by 36
Leslie, P. J., Jung, R. T., Isles, T. E., Baty, J. D., Newton, R. W., & Illingworth, P. J. (1986) · BMJ · doi:10.1136/bmj.293.6555.1121 · Cited by 35
(1988) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068185 · Cited by 35
Schäfer, G. (1980) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(80)90049-2 · Cited by 32
Postreceptor effect of metformin on insulin action in mice
Lord, J. M., Puah, J. A., Atkins, T. W., & Bailey, C. J. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb04977.x · Cited by 31
Self-citationGawler, D. J., Milligan, G., & Houslay, M. D. (1988) · Biochemical Journal · doi:10.1042/bj2490537 · Cited by 30
Effect of metformin on insulin binding to receptors in cultured human lymphocytes and cancer cells
PEZZINO, V., Trischitta, V., Purrello, F., & Vigneri, R. (1982) · Diabetologia · doi:10.1007/bf01271174 · Cited by 28
Effect of metformin on lipid metabolism in the rabbit aortic wall
Marquié, G. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90043-6 · Cited by 23
Metformin enhances certain insulin actions in cultured rat hepatoma cells
Purrello, F., Gullo, D., Buscema, M., PEZZINO, V., Vigner, R., & Goldfine, I. D. (1988) · Diabetologia · doi:10.1007/bf02341508 · Cited by 18
Plasma fibrinogen in diabetes mellitus.
Silva, S. R. D., Shawe, J. E., Patel, H., & Cudworth, A. G. (1979) · PubMed · Cited by 17
METFORMIN COMPARED WITH TOLBUTAMIDE IN THE TREATMENT OF MATURITY‐ONSET DIABETES MELLITUS
Lim, P., & Khoo, O. T. (1970) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1970.tb77850.x · Cited by 17
Coscelli, C., Palmari, V., Saccardi, F., Alpi, O., & Bonora, E. (1984) · Current Therapeutic Research · Cited by 13
Gregorio, F., Filipponi, P., Ambrosi, F., Cristallini, S., Marchetti, P., Calafiore, R., Navalesi, R., & Brunetti, P. (1989) · PubMed · Cited by 7
Treatment of the obese diabetic patient.
Db, S. (1967) · PubMed · Cited by 4
Cited by
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Self-citationKinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Metadata
- Authors
- Bailey, C. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1992-06-01
- Volume
- 15
- Issue
- 6
- Pages
- 755-772
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2056347227
- Cited by
- 593
- References
- 64
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.